The coronavirus pandemic has had profound negative impacts on large swaths of the U.S. economy. However, certain sectors like the life sciences have remained steady or have even grown, as many of these companies have pivoted to producing COVID-19-related tests, materials, therapeutics, and vaccines.
Well to say that the first two quarters of 2020 have been eventful in the life science sector is the understatement of the century. The BioBuzz team has been there for every twist and turn as the coronavirus pandemic reshaped everyday life and galvanized the BioHealth Capital Region (BHCR) to rise up and fight COVID-19.
Five BioHealth Capital Region Companies Make List of Largest COVID-19 Government Contracts At BioBuzz, we’ve been chronicling the BioHealth Capital Region’s contributions to the battle against the coronavirus pandemic. We’ve [….]
Good News Stories of the Week – Featuring the Baltimore Spirits Company, Route One Apparel, and More.
Good News Stories of the Week – Featuring the Baltimore Spirits Company, Route One Apparel, and More. The coronavirus pandemic and its impacts are changing daily and are hard to [….]
Everything You Need to Know About COVID-19 Testing The road to “normalcy” and the gradual reopening of the U.S. economy depends on reliable and widely available SARS-CoV-2 testing. While a [….]
“Claudia Towles owner of aMuse Toys said her company adjusted with the closure of non-essential businesses and shifted to retool the business for online orders, curbside pickup, and local deliveries.” [….]
Veteran Owned Diagnostics Supplier Tapped to Help alleviate COVID-19 Sample Collection Shortages April 28, 2020 Longhorn Vaccines & Diagnostics, located in Bethesda, Maryland, is a privately-held, veteran-run company that develops [….]
Good News Stories of the Week – Featuring Donations, Facemasks, Tests and More. Governor Hogan Announces Acquisition of 500K Tests from South Korea Maryland’s Governor Larry Hogan announced this week [….]
Weekly Roundup of COVID-19 Progress From T-Cell to Microbiome Therapies and FDA Emergency Use Applications
Weekly Roundup of COVID-19 Progress From T-Cell to Microbiome Therapies and FDA Emergency Use Applications April 21, 2020 Organizations from across the BioHealth Capital Region (BCHR) continue to pivot research, [….]
Six Johns Hopkins COVID-19 Programs that Reflect A Culture of Leadership from Clinical Research to Healthcare Innovation